Conventional-dose hormone therapy (HT) and tibolone, but not low-dose HT and raloxifene, increase markers of activated coagulation - Concepedia

Concepedia

Publication | Open Access

Conventional-dose hormone therapy (HT) and tibolone, but not low-dose HT and raloxifene, increase markers of activated coagulation

DOI Full Paper Access

31

Citations

50

References

2006

Year

Anette Løken Eilertsen, Elisabeth Qvigstad, Trine Opstad Andersen, Leiv Sandvik, Per Morten Sandset

ThrombosisBlood PlateletMedicineIncrease MarkersActivated CoagulationHematologyHemostasisPlatelet AntagonistPharmacotherapyConventional-dose Hormone TherapyCoagulopathyEndocrinologyPharmacologyAnticoagulant

References

	Year	Citations

Page 1

Page 1